MRI contrast agents

Details MRI contrast agents MRI contrast agents

2008-05-06

2008-05-06

Hartley, Michael G. (Department: 1618)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

Magnetic imaging agent

C424S009100, C424S009300

Reexamination Certificate

active

07368099

ABSTRACT:
An MRI contrast agent enables direct detection and imaging of exfoliated vascular endothelial sites. The MRI contrast agent includes an imaging unit which contains an unpaired electron-carrying atom and/or molecule and is capable of amplifying or reducing MRI signals, and a detection unit which is bonded to the imaging unit and is capable of selectively recognizing exfoliated vascular endothelial sites and binding thereto. The detection unit is exemplified by one having a chemical structure expressed by the following formula (I), wherein at least one of R1-R11is, for example, a sulfonic acid group, and X is, for example, a phenyl group which may be substituted:

REFERENCES:
patent: 2004/0204344 (2004-10-01), Huang
patent: WO0074727 (2000-12-01), None
Yamamoto et al. (Analytical Sciences 2004, 20, 5-7).
Dezutter et al. (Nucl. Med. Comm. 2001, 22, 553-558).

Affiliated with

Also associated with

Rating

MRI contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with MRI contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MRI contrast agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2797379